Menopause Hormone Therapy (HRT) in Shoreline, WA

Bioidentical hormones in Shoreline: what it means

Behind the label "bioidentical hormone replacement therapy" is a plain idea: a hormone whose structure matches the body's own. Two hormones used in menopause care fit it exactly, estradiol and micronized progesterone. FDA-approved versions of both are sold by prescription at retail pharmacies.

Only 3 OB-GYNs list a primary practice address in Shoreline in the NPI registry. For 59,280 residents that is 5.1 per 100,000, under the US 17.8 and below Washington's 17.0. Set against the city's 7,551 women aged 45 to 64, that is one OB-GYN for roughly every 2,520.

Widen the circle and the count grows: 266 in the city or within 10 miles, 631 within 25 miles. For the 2,731,653 people who live within 25 miles, that is 23.1 per 100,000. VevaMD is an online option alongside them: a physician licensed in Washington reviews your intake from Shoreline without an office visit, and an OB-GYN you already see stays your doctor.

"BHRT" often means compounded hormones, a cream, a blend such as Bi-Est or a pellet that a pharmacy mixes for one prescription. They are not FDA-approved, which means the FDA cannot assure their safety or effectiveness. The FDA says it has no evidence that compounded "bioidentical hormones" are safe and effective, or more effective than FDA-approved hormone therapy. The National Academies, reviewing them for the FDA in 2020, called their wide use a public health concern.

For women in Shoreline, a physician licensed in Washington can prescribe estradiol (pill, patch, cream or vaginal) and progesterone when they fit your history. There are no pellets. The pharmacy that fills VevaMD prescriptions also compounds, so ask your physician whether yours is an FDA-approved product or compounded. Two options are compounded for certain: testosterone cream for women and Bi-Est are not FDA-approved.

A pellet clinic is a different model: it implants a hormone pellet under the skin during a visit, and compounded pellets are not FDA-approved. The Endocrine Society points to a study that found hormone levels well above the expected range in women using them. ACOG's guidance is to prefer FDA-approved menopause hormone therapy to compounded hormones.

Sources: FDA: Menopause · FDA: National Academies study of compounded bioidentical hormones (2020) · Endocrine Society position statement on compounded bioidentical hormones (2019) · ACOG Clinical Consensus No. 6, compounded bioidentical menopausal hormone therapy (2023) · CMS NPPES NPI full file, 2026-10-11